Your browser doesn't support javascript.
loading
Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement.
Wada, Naoki; Abe, Noriyuki; Miyauchi, Kotona; Ishikawa, Mayumi; Makino, Shogo; Kakizaki, Hidehiro.
Afiliação
  • Wada N; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan. nwada@asahikawa-med.ac.jp.
  • Abe N; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
  • Miyauchi K; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
  • Ishikawa M; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
  • Makino S; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
  • Kakizaki H; Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
Int Urol Nephrol ; 54(1): 31-36, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34767140

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antagonistas Adrenérgicos alfa / Inibidores de 5-alfa Redutase / Sintomas do Trato Urinário Inferior / Dutasterida Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antagonistas Adrenérgicos alfa / Inibidores de 5-alfa Redutase / Sintomas do Trato Urinário Inferior / Dutasterida Idioma: En Ano de publicação: 2022 Tipo de documento: Article